Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Caitlin Marie Burk, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Alvarez-Arango S, Ogunwole SM, Sequist TD, Burk CM, Blumenthal KG. Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome". N Engl J Med. 2021 Apr 08; 384(14):1283-1286. PMID: 33830710.
    Citations:    Fields:    
  2. Burk CM, Coffey KE, Mace EM, Bostwick BL, Chinn IK, Coban-Akdemir ZH, Jhangiani SN, Lupski JR, Ortiz D, Barnum JL, Allen SW, Robertson LM, Orange JS, Chong HJ. Immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome with NK dysfunction and EBV-driven malignancy treated with stem cell transplantation. J Allergy Clin Immunol Pract. 2020 03; 8(3):1103-1106.e3. PMID: 31520839.
    Citations: 1     Fields:    
  3. Orgel K, Burk C, Smeekens J, Suber J, Hardy L, Guo R, Burks AW, Kulis M. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness. Clin Exp Allergy. 2019 04; 49(4):461-470. PMID: 30383313.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  4. Runge TM, Eluri S, Cotton CC, Burk CM, Woosley JT, Shaheen NJ, Dellon ES. Causes and Outcomes of Esophageal Perforation in Eosinophilic Esophagitis. J Clin Gastroenterol. 2017 Oct; 51(9):805-813. PMID: 27680593.
    Citations: 6     Fields:    Translation:Humans
  5. Burk CM, Dellon ES, Steele PH, Virkud YV, Kulis M, Burks AW, Vickery BP. Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab. J Allergy Clin Immunol Pract. 2017 Mar - Apr; 5(2):498-501. PMID: 28017628.
    Citations: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
  6. Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, Keet CA, Kulis M, Orgel KG, Guo R, Steele PH, Virkud YV, Ye P, Wright BL, Wood RA, Burks AW. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J Allergy Clin Immunol. 2017 01; 139(1):173-181.e8. PMID: 27522159.
    Citations: 48     Fields:    Translation:HumansAnimals
  7. Burk CM, Long MD, Dellon ES. Management of Eosinophilic Esophagitis During Pregnancy. Dig Dis Sci. 2016 07; 61(7):1819-25. PMID: 26888769.
    Citations: 1     Fields:    Translation:Humans
  8. Runge TM, Eluri S, Cotton CC, Burk CM, Woosley JT, Shaheen NJ, Dellon ES. Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype. Am J Gastroenterol. 2016 Feb; 111(2):206-13. PMID: 26753894.
    Citations: 30     Fields:    Translation:Humans
  9. Eluri S, Runge TM, Cotton CC, Burk CM, Wolf WA, Woosley JT, Shaheen NJ, Dellon ES. The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis. Gastrointest Endosc. 2016 Jun; 83(6):1142-8. PMID: 26608127.
    Citations: 28     Fields:    Translation:Humans
  10. Bird JA, Feldman M, Arneson A, Dougherty I, Brown LS, Burk CM, Kulis M, Burks W, Gill M. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization. J Allergy Clin Immunol Pract. 2015 May-Jun; 3(3):433-5.e1-3. PMID: 25609341.
    Citations: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
  11. White BL, Shi X, Burk CM, Kulis M, Burks AW, Sanders TH, Davis JP. Strategies to mitigate peanut allergy: production, processing, utilization, and immunotherapy considerations. Annu Rev Food Sci Technol. 2014; 5:155-76. PMID: 24387606.
    Citations: 1     Fields:    Translation:HumansAnimals
  12. Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014 Feb; 133(2):468-75. PMID: 24361082.
    Citations: 102     Fields:    Translation:HumansAnimals
  13. Bird JA, Kulis M, Burk CM, Vickery BP, Jones SM, Burks W. Tree nut- and sesame-specific IgE do not decrease from baseline with peanut oral immunotherapy (OIT). Ann Allergy Asthma Immunol. 2012 Dec; 109(6):470-1. PMID: 23176890.
    Citations: 2     Fields:    Translation:HumansAnimals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Burk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (79)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.